Transcriptional consequences of genomic structural aberrations in breast cancer

Genome Research

Volumn 21, Issue 5, 2011, Pages 676-687

  Inaki, Koichiro ^a   Hillmer, Axel M ^a   Ukil, Leena ^a   Yao, Fei ^a,b   Woo, Xing Yi ^a   Vardy, Leah A ^c   Zawack, Kelson Folkvard Braaten ^a   Lee, Charlie Wah Heng ^a   Ariyaratne, Pramila Nuwantha ^a   Chan, Yang Sun ^a   Desai, Kartiki Vasant ^a   Bergh, Jonas ^d   Hall, Per ^d   Putti, Thomas Choudary ^e   Ong, Wai Loon ^a   Shahab, Atif ^a   Cacheux Rataboul, Valere ^a   Karuturi, Radha Krishna Murthy ^a   Sung, Wing Kin ^a   Ruan, Xiaoan ^a   Bourque, Guillaume ^a   Ruan, Yijun ^a   Liu, Edison T ^a   more..

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^d KAROLINSKA INSTITUTE   (Sweden)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER GENETICS; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENE STRUCTURE; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE REARRANGEMENT; GENOME, HUMAN; GENOMIC INSTABILITY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MEMBRANE PROTEINS; RECOMBINANT FUSION PROTEINS; RIBOSOMAL PROTEIN S6 KINASES; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC;

EID: 79955560249     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.113225.110     Document Type: Article

References (45)

1. Bärlund M, Forozan F, Kononen J, Bubendorf L, Chen Y, Bittner ML, Torhorst J, Haas P, Bucher C, Sauter G, et al. 2000. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J Natl Cancer Inst 92: 1252-1259. (Pubitemid 30627733)
2. Bärlund M, Monni O, Weaver JD, Kauraniemi P, Sauter G, Heiskanen M, Kallioniemi OP, Kallioniemi A. 2002. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer. Genes Chromosomes Cancer 35: 311-317. (Pubitemid 35246989)
3. Bashir A, Volik S, Collins C, Bafna V, Raphael BJ. 2008. Evaluation of paired-end sequencing strategies for detection of genome rearrangements in cancer. PLoS Comput Biol 4: e1000051. doi: 10.1371/journal.pcbi. 1000051.
4. Beilharz TH, Preiss T. 2004. Translational profiling: The genome-wide measure of the nascent proteome. Brief Funct Genomic Proteomic 3: 103-111.
5. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, et al. 2010. The landscape of somatic copy-number alteration across human cancers. Nature 463: 899-905.
6. Cerione RA, Zheng Y. 1996. The Dbl family of oncogenes. Curr Opin Cell Biol 8: 216-222. (Pubitemid 26109095)
7. Chen S, HammHE. 2006. DEP domains: more than just membrane anchors. Dev Cell 11: 436-438.
8. Fullwood MJ, Liu MH, Pan YF, Liu J, Xu H, Mohamed YB, Orlov YL, Velkov S, Ho A, Mei PH, et al. 2009. An oestrogen-receptor-a-bound human chromatin interactome. Nature 462: 58-64.
9. Hahn Y, Bera TK, Gehlhaus K, Kirsch IR, Pastan IH, Lee B. 2004. Finding fusion genes resulting from chromosome rearrangement by analyzing the expressed sequence databases. Proc Natl Acad Sci 101: 13257-13261. (Pubitemid 39209652)
10. Hampton OA, Den Hollander P, Miller CA, Delgado DA, Li J, Coarfa C, Harris RA, Richards S, Scherer SE, Muzny DM, et al. 2009. A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome. Genome Res 19: 167-177.
11. Helgeson BE, Tomlins SA, Shah N, Laxman B, Cao Q, Prensner JR, Cao X, Singla N, Montie JE, Varambally S, et al. 2008. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Cancer Res 68: 73-80. (Pubitemid 351380107)
12. Hillmer AM, Yao F, Inaki K, LeeWH, Ariyaratne PN, Teo ASM,Woo XY, Zhang Z, Zhao H, Ukil L, et al. 2011. Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes. Genome Res (this issue). doi: 10.1101/gr.113555.110.
13. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, et al. 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070. (Pubitemid 41161233)
14. Ivshina AV, George J, Senko O, Mow B, Putti TC, Smeds J, Lindahl T, Pawitan Y, Hall P, Nordgren H, et al. 2006. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 66: 10292-10301. (Pubitemid 44799747)
15. Janz S, Potter M, Rabkin CS. 2003. Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer 36: 211-223. (Pubitemid 36158194)
16. Joosten M, Blázquez-Domingo M, Lindeboom F, Boulmé F, Van Hoven-Beijen A, Habermann B, Löwenberg B, Beug H, Müllner EW, Delwel R, et al. 2004. Translational control of putative protooncogene Nm23-M2 by cytokines via phosphoinositide 3-kinase signaling. J Biol Chem 279: 38169-38176. (Pubitemid 39295963)
17. Kidd JM, Cooper GM, Donahue WF, Hayden HS, Sampas N, Graves T, Hansen N, Teague B, Alkan C, Antonacci F, et al. 2008. Mapping and sequencing of structural variation from eight human genomes. Nature 453: 56-64. (Pubitemid 351630326)
18. Korbel JO, Urban AE, Affourtit JP, Godwin B, Grubert F, Simons JF, Kim PM, Palejev D, Carriero NJ, Du L, et al. 2007. Paired-end mapping reveals extensive structural variation in the human genome. Science 318: 420-426. (Pubitemid 47614521)
19. Li D, Roberts R. 2001. WD-repeat proteins: structure characteristics, biological function, and their involvement in human diseases. Cell Mol Life Sci 58: 2085-2097. (Pubitemid 34016977)
20. Li Z, Tognon CE, Godinho FJ, Yasaitis L, Hock H, Herschkowitz JI, Lannon CL, Cho E, Kim SJ, Bronson RT, et al. 2007. ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex. Cancer Cell 12: 542-558. (Pubitemid 350199073)
21. Li H, Wang J, Mor G, Sklar J. 2008. A neoplastic gene fusion mimics transsplicing of RNAs in normal human cells. Science 321: 1357-1361.
22. Lin E, Li L, Guan Y, Soriano R, Rivers CS, Mohan S, Pandita A, Tang J, Modrusan Z. 2009. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers. Mol Cancer Res 7: 1466-1476.
23. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. 2002. The protein kinase complement of the human genome. Science 298: 1912-1934. (Pubitemid 35425239)
24. Mitelman F, Johansson B, Mertens F. 2007. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7: 233-245. (Pubitemid 46480968)
25. Ng P, Tan JJ, Ooi HS, Lee YL, Chiu KP, Fullwood MJ, Srinivasan KG, Perbost C, Du L, Sung WK, et al. 2006. Multiplex sequencing of paired-end ditags (MS-PET): a strategy for the ultra-high-throughput analysis of transcriptomes and genomes. Nucleic Acids Res 34: e84. doi: 10.1093/nar/gkl444.
26. Provenzani A, Fronza R, Loreni F, Pascale A, Amadio M, Quattrone A. 2006. Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis. Carcinogenesis 27: 1323-1333. (Pubitemid 43985407)
27. Rabbitts TH. 2009. Commonality but diversity in cancer gene fusions. Cell 137: 391-395.
28. Raphael BJ, Volik S, Yu P, Wu C, Huang G, Linardopoulou EV, Trask BJ, Waldman F, Costello J, Pienta KJ, et al. 2008. A sequence-based survey of the complex structural organization of tumor genomes. Genome Biol 9: R59. doi: 10.1186/gb-2008-9-3-r59.
29. Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, Nardone J, Lee K, Reeves C, Li Y, et al. 2007. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131: 1190-1203. (Pubitemid 350235027)
30. Ruan X, Ruan Y. 2011. Genome wide full-length transcript analysis using 5′ and 3′ paired-end-tag next generation sequencing (RNA-PET). In Transcriptional regulation: Methods and protocols. Methods in molecular biology (ed. Ales Vancura). Humana Press, Totowa, NJ (in press).
31. Ruan Y, Ooi HS, Choo SW, Chiu KP, Zhao XD, Srinivasan KG, Yao F, Choo CY, Liu J, Ariyaratne P, et al. 2007. Fusion transcripts and transcribed retrotransposed loci discovered through comprehensive transcriptome analysis using Paired-End diTags (PETs). Genome Res 17: 828-838. (Pubitemid 46919718)
32. Sampath P, Pritchard DK, Pabon L, Reinecke H, Schwartz SM, Morris DR, Murry CE. 2008. A hierarchical network controls protein translation during murine embryonic stem cell self-renewal and differentiation. Cell Stem Cell 2: 448-460. (Pubitemid 351598082)
33. Sinclair CS, Rowley M, Naderi A, Couch FJ. 2003. The 17q23 amplicon and breast cancer. Breast Cancer Res Treat 78: 313-322. (Pubitemid 36543211)
34. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, et al. 2007. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448: 561-566. (Pubitemid 47206930)
35. Stephens PJ, McBride DJ, Lin ML, Varela I, Pleasance ED, Simpson JT, Stebbings LA, Leroy C, Edkins S, Mudie LJ, et al. 2009. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 462: 1005-1010.
36. Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA, Becker L, Carneiro F, MacPherson N, Horsman D, et al. 2002. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2: 367-376.
37. -/- embryonic stem cells. Mol Cell Biol 25: 8465-8475.
38. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, et al. 2005. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644-648. (Pubitemid 41528150)
39. Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, Menon A, Jing X, Cao Q, Han B, et al. 2007. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448: 595-599. (Pubitemid 47206938)
40. Tomlins SA, Laxman B, Varambally S, Cao X, Yu J, Helgeson BE, Cao Q, Prensner JR, Rubin MA, Shah RB, et al. 2008. Role of the TMPRSS2-ERG gene fusion in prostate cancer. Neoplasia 10: 177-188. (Pubitemid 351240884)
41. Volik S, Raphael BJ, Huang G, Stratton MR, Bignel G, Murnane J, Brebner JH, Bajsarowicz K, Paris PL, Tao Q, et al. 2006. Decoding the fine-scale structure of a breast cancer genome and transcriptome. Genome Res 16: 394-404. (Pubitemid 43327510)
42. Wang H, Vardy LA, Tan CP, Loo JM, Guo K, Li J, Lim SG, Zhou J,Chng WJ, Ng SB, et al. 2010. PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase. Cancer Cell 18: 52-62.
43. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY. 2008. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14: 2348-2360.
44. Zhang J, Liu X, Datta A, Govindarajan K, TamWL, Han J, George J,Wong C, Ramnarayanan K, Phua TY, et al. 2009a. RCP is a human breast cancerpromoting gene with Ras-activating function. J Clin Invest 119: 2171-2183.
45. Zhang X, Lian Z, Padden C, Gerstein MB, Rozowsky J, Snyder M, Gingeras TR, Kapranov P, Weissman SM, Newburger PE. 2009b. A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster. Blood 113: 2526-2534.